Hepatitis Monthly

Published by: Kowsar

Seropositive Form of Occult Hepatitis B Virus Infection in Iranian Patients with Cryptogenic Liver Cirrhosis

Javad Moayedi 1 , 2 , Maryam Moini 3 , Bita Geramizadeh 1 , Seyed Ali Malekhosseini 1 and Ramin Yaghobi 1 , *
Authors Information
1 Shiraz Transplant Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
2 Department of Microbiology, Jahrom Branch, Islamic Azad University, Jahrom, Iran
3 Department of Internal Medicine, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
Article information
  • Hepatitis Monthly: March 31, 2019, 19 (3); e84806
  • Published Online: March 27, 2019
  • Article Type: Research Article
  • Received: September 30, 2018
  • Revised: March 5, 2019
  • Accepted: March 10, 2019
  • DOI: 10.5812/hepatmon.84806

To Cite: Moayedi J, Moini M, Geramizadeh B, Malekhosseini S A , Yaghobi R. Seropositive Form of Occult Hepatitis B Virus Infection in Iranian Patients with Cryptogenic Liver Cirrhosis, Hepat Mon. 2019 ; 19(3):e84806. doi: 10.5812/hepatmon.84806.

Copyright © 2019, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
  • 1. Yaghobi R, Kazemi MJ, Geramizadeh B, Malek Hosseini SA, Moayedi J. Significance of occult hepatitis C virus Infection in liver transplant patients with cryptogenic cirrhosis. Exp Clin Transplant. 2018. doi: 10.6002/ect.2017.0332. [PubMed: 30346262].
  • 2. Desai HG. Cryptogenic cirrhosis: A vanishing entity. J Assoc Physicians India. 2009;57:751-4. 759. [PubMed: 20329442].
  • 3. Alamo JM, Bernal C, Barrera L, Marin LM, Suarez G, Serrano J, et al. Liver transplantation in patients with cryptogenic cirrhosis: Long-term follow-up. Transplant Proc. 2011;43(6):2230-2. doi: 10.1016/j.transproceed.2011.05.017. [PubMed: 21839241].
  • 4. Marmur J, Bergquist A, Stal P. Liver transplantation of patients with cryptogenic cirrhosis: Clinical characteristics and outcome. Scand J Gastroenterol. 2010;45(1):60-9. doi: 10.3109/00365520903384742. [PubMed: 20030578].
  • 5. Keyvani H, Bokharaei-Salim F, Monavari SH, Esghaei M, Nassiri Toosi M, Fakhim S, et al. Occult hepatitis C virus infection in candidates for liver transplant with cryptogenic cirrhosis. Hepat Mon. 2013;13(8). e11290. doi: 10.5812/hepatmon.11290. [PubMed: 24082889]. [PubMed Central: PMC3785931].
  • 6. Sarma MP, Asim M, Medhi S, Bharathi T, Diwan R, Kar P. Viral genotypes and associated risk factors of hepatocellular carcinoma in India. Cancer Biol Med. 2012;9(3):172-81. doi: 10.7497/j.issn.2095-3941.2012.03.004. [PubMed: 23691475]. [PubMed Central: PMC3643662].
  • 7. Michitaka K, Nishiguchi S, Aoyagi Y, Hiasa Y, Tokumoto Y, Onji M, et al. Etiology of liver cirrhosis in Japan: A nationwide survey. J Gastroenterol. 2010;45(1):86-94. doi: 10.1007/s00535-009-0128-5. [PubMed: 19789837].
  • 8. Behzad-Behbahani A, Mojiri A, Tabei SZ, Farhadi-Andarabi A, Pouransari R, Yaghobi R, et al. Outcome of hepatitis B and C virus infection on graft function after renal transplantation. Transplant Proc. 2005;37(7):3045-7. doi: 10.1016/j.transproceed.2005.07.039. [PubMed: 16213299].
  • 9. Ghanbari R, Ravanshad M, Hosseini SY, Yaghobi R, Shahzamani K. Genotyping and infection rate of GBV-C among Iranian HCV- infected patients. Hepat Mon. 2010;10(2):80-7. [PubMed: 22312378]. [PubMed Central: PMC3270361].
  • 10. Kazemi MJ, Yaghobi R, Iravani Saadi M, Geramizadeh B, Moayedi J. Association between TT virus Infection and cirrhosis in liver transplant patients. Hepat Mon. 2015;15(9). e28370. doi: 10.5812/hepatmon.28370. [PubMed: 26504468]. [PubMed Central: PMC4612723].
  • 11. Janfeshan S, Yaghobi R, Eidi A, Karimi MH, Geramizadeh B, Malekhosseini SA, et al. Study the cross-talk between hepatitis B virus Infection and Interferon regulatory factors in liver transplant patients. Hepat Mon. 2017;17(11). e12426. doi: 10.5812/hepatmon.12426.
  • 12. Kao JH, Chen PJ, Lai MY, Chen DS. Occult hepatitis B virus infection and clinical outcomes of patients with chronic hepatitis C. J Clin Microbiol. 2002;40(11):4068-71. doi: 10.1128/JCM.40.11.4068-4071.2002. [PubMed: 12409376]. [PubMed Central: PMC139665].
  • 13. Chan HL, Tsang SW, Leung NW, Tse CH, Hui Y, Tam JS, et al. Occult HBV infection in cryptogenic liver cirrhosis in an area with high prevalence of HBV infection. Am J Gastroenterol. 2002;97(5):1211-5. doi: 10.1111/j.1572-0241.2002.05706.x. [PubMed: 12014730].
  • 14. Samal J, Kandpal M, Vivekanandan P. Molecular mechanisms underlying occult hepatitis B virus infection. Clin Microbiol Rev. 2012;25(1):142-63. doi: 10.1128/CMR.00018-11. [PubMed: 22232374]. [PubMed Central: PMC3255968].
  • 15. Raimondo G, Caccamo G, Filomia R, Pollicino T. Occult HBV infection. Semin Immunopathol. 2013;35(1):39-52. doi: 10.1007/s00281-012-0327-7. [PubMed: 22829332]. [PubMed Central: PMC3540364].
  • 16. Sumera N. Occult hepatitis B virus Infection (OBI) and liver disease. Pak J Med Res. 2014;53(1):1-2.
  • 17. Hu KQ. Occult hepatitis B virus infection and its clinical implications. J Viral Hepat. 2002;9(4):243-57. doi: 10.1046/j.1365-2893.2002.00344.x. [PubMed: 12081601].
  • 18. Helaly GF, El Ghazzawi EF, Shawky SM, Farag FM. Occult hepatitis B virus infection among chronic hemodialysis patients in Alexandria, Egypt. J Infect Public Health. 2015;8(6):562-9. doi: 10.1016/j.jiph.2015.04.019. [PubMed: 26026236].
  • 19. Schmeltzer P, Sherman KE. Occult hepatitis B: Clinical implications and treatment decisions. Dig Dis Sci. 2010;55(12):3328-35. doi: 10.1007/s10620-010-1413-0. [PubMed: 20927592]. [PubMed Central: PMC3001399].
  • 20. Allain JP. Occult hepatitis B virus infection. Transfus Clin Biol. 2004;11(1):18-25. doi: 10.1016/j.tracli.2003.11.007. [PubMed: 14980545].
  • 21. Ferrari TC, Xavier MA, Vidigal PV, Amaral NS, Diniz PA, Resende AP, et al. Occult hepatitis B virus infection in liver transplant patients in a Brazilian referral center. Braz J Med Biol Res. 2014;47(11):990-4. doi: 10.1590/1414-431X20143782. [PubMed: 25296362]. [PubMed Central: PMC4230290].
  • 22. Hashemi SJ, Hajiani E, Masjedizadeh A, Makvandi M, Shayesteh AA, Alavinejad SP, et al. Occult hepatitis B infection in patients with cryptogenic liver cirrhosis in southwest of iran. Jundishapur J Microbiol. 2015;8(3). e16873. doi: 10.5812/jjm.16873. [PubMed: 25861432]. [PubMed Central: PMC4386076].
  • 23. Alavian SM, Fallahian F, Lankarani KB. The changing epidemiology of viral hepatitis B in Iran. J Gastrointestin Liver Dis. 2007;16(4):403-6. [PubMed: 18193122].
  • 24. Honarkar Z, Alavian SM, Samiee S, Saeedfar K, Zali MR. Occult hepatitis B among chronic liver disease patients. Saudi Med J. 2005;26(4):601-6. [PubMed: 15900369].
  • 25. Anvari FA, Alavian SM, Norouzi M, Mahabadi M, Jazayeri SM. Prevalence and molecular analysis of occult hepatitis B virus infection isolated in a sample of cryptogenic cirrhosis patients in iran. Oman Med J. 2014;29(2):92-6. doi: 10.5001/omj.2014.23. [PubMed: 24715933]. [PubMed Central: PMC3976723].
  • 26. Maheshwari A, Thuluvath PJ. Cryptogenic cirrhosis and NAFLD: Are they related? Am J Gastroenterol. 2006;101(3):664-8. doi: 10.1111/j.1572-0241.2006.00478.x. [PubMed: 16464222].
  • 27. Alhababi F, Sallam TA, Tong CY. The significance of 'anti-HBc only' in the clinical virology laboratory. J Clin Virol. 2003;27(2):162-9. doi: 10.1016/S1386-6532(02)00171-3. [PubMed: 12829038].
  • 28. Hou J, Liu Z, Gu F. Epidemiology and prevention of hepatitis B virus Infection. Int J Med Sci. 2005;2(1):50-7. doi: 10.7150/ijms.2.50. [PubMed: 15968340]. [PubMed Central: PMC1142225].
  • 29. Makvandi M. Update on occult hepatitis B virus infection. World J Gastroenterol. 2016;22(39):8720-34. doi: 10.3748/wjg.v22.i39.8720. [PubMed: 27818588]. [PubMed Central: PMC5075547].
  • 30. Sutedja DS, Gow PJ, Hubscher SG, Elias E. Revealing the cause of cryptogenic cirrhosis by posttransplant liver biopsy. Transplant Proc. 2004;36(8):2334-7. doi: 10.1016/j.transproceed.2004.07.003. [PubMed: 15561241].
  • 31. Duclos-Vallee JC, Yilmaz F, Johanet C, Roque-Afonso AM, Gigou M, Trichet C, et al. Could post-liver transplantation course be helpful for the diagnosis of so called cryptogenic cirrhosis? Clin Transplant. 2005;19(5):591-9. doi: 10.1111/j.1399-0012.2004.00323.x. [PubMed: 16146549].
  • 32. Sakugawa H, Nakasone H, Nakayoshi T, Kawakami Y, Yamashiro T, Maeshiro T, et al. Clinical characteristics of patients with cryptogenic liver cirrhosis in Okinawa, Japan. Hepatogastroenterology. 2003;50(54):2005-8. [PubMed: 14696453].
  • 33. Leite AB, Mattos AA, Mattos AZ, Coral GP, Evaldt S. Risk factors for nonalcoholic steatohepatitis in cryptogenic cirrhosis. Arq Gastroenterol. 2012;49(4):245-9. doi: 10.1590/S0004-28032012000400003. [PubMed: 23329217].
  • 34. Branco F, Mattos AA, Coral GP, Vanderborght B, Santos DE, Franca P, et al. Occult hepatitis B virus infection in patients with chronic liver disease due to hepatitis C virus and hepatocellular carcinoma in Brazil. Arq Gastroenterol. 2007;44(1):58-63. doi: 10.1590/S0004-28032007000100013. [PubMed: 17639185].
  • 35. Xie M, Rao W, Yang T, Deng Y, Zheng H, Pan C, et al. Occult hepatitis B virus infection predicts de novo hepatitis B infection in patients with alcoholic cirrhosis after liver transplantation. Liver Int. 2015;35(3):897-904. doi: 10.1111/liv.12567. [PubMed: 24750566].
  • 36. Cholongitas E, Papatheodoridis GV, Burroughs AK. Liver grafts from anti-hepatitis B core positive donors: A systematic review. J Hepatol. 2010;52(2):272-9. doi: 10.1016/j.jhep.2009.11.009. [PubMed: 20034693].
  • 37. Pollicino T, Squadrito G, Cerenzia G, Cacciola I, Raffa G, Craxi A, et al. Hepatitis B virus maintains its pro-oncogenic properties in the case of occult HBV infection. Gastroenterology. 2004;126(1):102-10. doi: 10.1053/j.gastro.2003.10.048. [PubMed: 14699492].
  • 38. Brechot C. Pathogenesis of hepatitis B virus-related hepatocellular carcinoma: Old and new paradigms. Gastroenterology. 2004;127(5 Suppl 1):S56-61. doi: 10.1053/j.gastro.2004.09.016. [PubMed: 15508104].
  • 39. Agarwal N, Naik S, Aggarwal R, Singh H, Somani SK, Kini D, et al. Occult hepatitis B virus infection as a cause of cirrhosis of liver in a region with intermediate endemicity. Indian J Gastroenterol. 2003;22(4):127-31. [PubMed: 12962434].
  • 40. Kaviani MJ, Behbahani B, Mosallaii MJ, Sari-Aslani F, Taghavi SA. Occult hepatitis B virus infection and cryptogenic chronic hepatitis in an area with intermediate prevalence of HBV infection. World J Gastroenterol. 2006;12(31):5048-50. doi: 10.3748/wjg.v12.i31.5048. [PubMed: 16937504]. [PubMed Central: PMC4087411].
  • 41. Heringlake S, Schutte A, Flemming P, Schmiegel W, Manns MP, Tillmann HL. Presumed cryptogenic liver disease in Germany: High prevalence of autoantibody-negative autoimmune hepatitis, low prevalence of NASH, no evidence for occult viral etiology. Z Gastroenterol. 2009;47(5):417-23. doi: 10.1055/s-0028-1109146. [PubMed: 19418409].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments